- Fee assured
- Verified this account
This healthcare professional let us know that they are currently:
- Accepting new patients
- Available for:
- Face-to-face consultations
- Phone consultations
Last updated: 18 Sep 2020
- Breast surgery
TRAINING & APPOINTMENTS:
Mrs Jagdeep K Singh read Medicine at Somerville College, University of Oxford and graduated from University College London in 2005. She completed her Higher Surgical Training in the West Midlands and undertook specialist breast training at major university teaching hospitals including University Hospitals Birmingham NHS Foundation Trust. She was awarded her Certificate of Completion of Training in 2018 and worked as a Consultant Oncoplastic Breast Surgeon at the Queen Elizabeth Hospital, part of University Hospitals Birmingham NHS Foundation Trust, between June 2018 and July 2020. She was the Breast Angiosarcoma Lead for the West Midlands and established the regional Electrochemotherapy service at the Queen Elizabeth Hospital for breast cancer patients with skin metastases. She was awarded the Silver Medal in the European Board of Surgery Examinations in Breast Surgery in 2018. She relocated to Guildford in July 2020 and was appointed as a Consultant Oncoplastic Breast Surgeon at Surrey and Sussex Healthcare NHS Trust in August 2020.
Mrs Singh has a strong academic background. She undertook 2 years of research at the internationally renowned Paterson Institute of Cancer Research and The Christie NHS Trust, Manchester between 2010 and 2012. Her research focused on developing novel treatments to stop the growth of breast cancer stem cells and she was awarded an Medical Doctorate (MD) from the University of Manchester in 2012. She was awarded a Royal College of Surgeons Surgical Research Fellowship (2010) and the Royal College of Surgeons Stefan Galeski Travelling Fellowship (2011). He research led to several high impact factor publications, international presentations and she was presented with the Allen Edwards Research Prize at the British Association of Surgical Oncology (BASO) Scientific Conference in 2011.
She was selected to join the National Cancer Research Institute Breast Clinical Studies Group through the Trainee Scheme in 2016 and she has continued to engage in clinical research. She was the Chief Investigator of the National Mastectomy Decisions Audit (MasDA) and she is on the steering group of other collaborative studies including the Neoadjuvant Systemic Treatment (NeST) study and the Breast Angiosarcoma Surveillance Study (BRASS). She is committed to improving the lives of breast cancer patient through research and is the Research Lead at Surrey and Sussex Healthcare NHS Trust.
Areas of interest
Breast cancer; family history; risk reducing surgery; benign breast disease; breast screening; oncoplastic breast surgery; breast reconstruction.
Breast cancer operations:
Wide local excision (lumpectomy); therapeutic mammoplasty (cancer surgery combined with re-shaping of the breast to give optimal cosmesis); mastectomy (simple, skin-sparing, skin-reducing, nipple-sparing, risk-reducing); sentinel lymph node biopsy; axillary node clearance; immediate implant-based breast reconstruction; immediate-delayed breast reconstruction utilising expanders; nipple reconstruction.
Benign breast operations:
Symmetrising mammoplasty; mastopexy (breast uplift); removal of implant; capsulectomy; lipomodelling (fat transfer); excision of benign breast lesions; diagnostic excisions; duct surgery; scar revision surgery; diagnostic biopsy of axillary lymph nodes.
Current NHS consultant posts held
Consultant Oncoplastic Breast Surgeon
Surrey and Sussex Healthcare NHS Trust
East Surrey Hospital
Breast cancer management, surgery and novel treatments. Collaborative research.
Spending time with my young family and when I can, skiing, running and entertaining family and friends.
Singh JK, McEvoy K, Marla S et al. Multicentre prospective observational study evaluating recommendations for mastectomy by multidisciplinary teams.
Br J Surg, 2020: 107(3): 227-237.
Irwin GW, Bannon F, Coles CE et al. The NeST (neoadjuvant systemic therapy in breast cancer) study - protocol for a prospective multi-centre cohort study to assess the current utilization and short-term outcomes of neoadjuvant systemic therapies in breast cancer. Int J of Surg Protocols, 2019: 18: 5-11.
Glasbey J, Nepogodiev D, Kamarajah S et al. Challenging traditional research: A synopsis of the National Research Collaborative Meeting (NRCM) in 2017. Int J of Surg Protocol, 2019: 15: 8-11.
Feinberg L, Srinivasan A, Singh JK et al. Impact of Specialist Management on Survival From Radiation-associated Angiosarcoma of the Breast. Br J Surg, 2018; 105: 401–409.
Lowry D, Singh JK, Mytton J et al. Sex-Related Outcome Inequalities in Endovascular Aneurysm Repair. Eur J Vasc Endovasc Surg, 2016; 52(4): 518-525.
Singh JK, Farnie G, Bundred NJ et al. Targeting CXCR1/2 Significantly Reduces Breast Cancer Stem Cell Activity and Increases the Efficacy of Inhibiting HER2 via HER2-dependent and –independent mechanisms. Clin Cancer Res, 2013; 19(3): 643-56.
Singh JK, Simões BM, Farnie G et al. Recent Advances Reveal IL-8 Signalling as a Potential Key to Targeting Breast Cancer Stem Cells. Breast Cancer Research, 2013; 15(4): 210-219.
Singh JK, Siamese BM, Clarke RB et al. Targeting IL-8 Signalling to Inhibit Breast Cancer Stem Cell Activity. Expert Opinion on Therapeutic Targets, 2013; 17(11): 1235-41.
Ablett MP, Singh JK and Clarke RB. Stem Cells in Breast Tumours: Are They Ready for the Clinic? Eur J Cancer, 2012; 48(14): 2104-16.
Singh JK, Singh P, Thomas W.E.G et al. Supporting Surgical Skills Training in Brunei and Borneo. Bulletin of The Royal Coll Surg Eng, 2011; 93(10): 343-344.
Singh JK and Singh P. Routine Pre-operative Cross-match for Elective Colorectal Resections: An appropriate Use of Resources? Surgeon, 2011; 9(1): 8-12.
Rai JK, Shankar A and Brookes J. A Rare Cause of Spontaneous Intra-abdominal Haemorrhage Due to Coeliac Artery Stenosis. Annals of the Royal Coll Surg Eng. Oct 2010.
Breuning E, Oikonomou D, Singh P et al. Cosmetic Surgery in the NHS: Applying Local and National Guidelines. JPRAS, 2010; 63(9): 1437-1442.
Mendonca DA, Rai JK and Porter JM. The Sandwell Incision in Dupuytren’s Fasciectomy. JPRAS, 2008; 62(2): 257.
Courses offered to GPs
Breast cancer, benign breast conditions, family history, oncoplastic breast surgery.
- BA (Hons) Physiological Sciences University of Oxford 2002
- MBBS University College London 2005
- FEBS (Breast Surgery) European Board of Surgery 2018
- FRCS Royal College of Surgeons of England 2017
- MD University of Manchester 2012
Reference number 6129797
Details of entry to specialist register
- General Surgery, 2018
Affiliations / memberships
Fellow of the Royal College of Surgeons of England
Fellow of the European Board of Surgery
Association of Breast Surgery
Women in Surgery, Royal College of Surgeons of England
General Medical Council
- Harvey RoadGUILDFORDGU1 3LX
- 15:00 - 17:00
- 07979 189533
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.
In the event of an urgent query following treatment, Bupa members should use the following contact details